Vera Therapeutics (VERA)

• Market cap: $2.81B
• 1 day: -7.95%
• 5 days: -7.19%
• 1 month: 16.19%
• 3 months: -7.39%
• 6 months: -15.89%
• Year to date: -19.54%
• 1 year: 66.04%
• 5 years: 163.43%
• 10 years: 240.17%
• Sector: Healthcare
• Industry: Biotechnology

About: Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Employees: 339